ADC Therapeutics SA — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-1
Book Value Per Share
$-1
Free Cash Flow Per Share
$-1
Cash Per Share
$2
Revenue Per Share
$1
OCF Per Share
$-1
Return on Equity
73.4%
Return on Assets
-44.2%
Return on Invested Capital
49.4%
Current Ratio
4.37
Quick Ratio
4.31
Asset Turnover
0.25
Days Payables Outstanding
577.59
Days Inventory On Hand
263.39
R&D / Revenue
127.8%
SBC / Revenue
8.5%
Capex / Revenue
0.3%
Working Capital
$236M
Net Current Asset Value
$-203M
Invested Capital
$-186M
OCF / Net Income
0.99
FCF / Net Income
0.99
Accruals Ratio (Sloan)
-0.4%
Net Debt
$-261M
Net Debt / EBITDA
2.16
Interest Coverage
-7.47
Cash Coverage
-8.67
Capex Coverage
-534.75
Tangible Common Equity
$-186M
TCE / Total Assets
-57.5%
NOPAT
$-96M
Cash ROIC
72.8%
WC / Revenue
290.3%
Capex / D&A
0.37
Reinvestment Rate
0.4%
Asset Growth vs Revenue Growth
-14.5%
Stock Price (FY-end)
$4
Market Cap
$449M
P/S Ratio
5.51
P/B Ratio
—
P/TB Ratio
—
Enterprise Value
$187M
EV / Sales
2.30
FCF Yield
-31.5%
Shareholder Yield
-1.5%
R&D Yield
23.2%
Capex Yield
0.1%
Shares Variation (YoY)
30.8%
Beta (5Y)
1.42
Cost of Equity
11.6%
52W High
$5
52W Low
$1
Trailing Return 1Y
73.9%
Trailing Return 5Y
-90.3%
F-Score (Piotroski)
5.00
Z-Score (Altman)
-6.67
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.